Literature DB >> 28992219

Childhood Health Outcomes in Term, Large-for-Gestational-Age Babies With Different Postnatal Growth Patterns.

Xiaoping Lei1,2, Dongying Zhao1, Lisu Huang1, Zhongcheng Luo1,3, Jun Zhang1,3, Xiaodan Yu1,3, Yongjun Zhang1.   

Abstract

Large-for-gestational-age (LGA) babies have a higher risk of metabolic disease later in life, and their postnatal growth in early childhood may be associated with long-term adverse outcomes. This study aimed to determine childhood health outcomes of term LGA babies with different growth patterns. Data were obtained from the US Collaborative Perinatal Project for the years between 1959 and 1976. The growth trajectories of 3,316 term LGA babies were identified and odds ratios of obesity, growth restriction, low intelligence quotient (IQ), and high blood pressure (HBP) were calculated by logistic regression. Compared with term appropriate-for-gestational-age infants, term LGA babies without catch-down growth had increased risks of obesity (adjusted odds ratio (aOR) = 6.37, 95% confidence interval (CI): 5.24, 7.73) and HBP (aOR = 1.67, 95% CI: 1.37, 2.03). Those with high catch-down growth had higher risks of growth restriction (aOR = 2.21, 95% CI: 1.66, 2.95) and low IQ (aOR = 1.61, 95% CI: 1.04, 2.49). Nevertheless, infants with small catch-down growth had lower risks of obesity (aOR = 0.78, 95% CI: 0.63, 0.95), growth restriction (aOR = 0.28, 95% CI: 0.17, 0.46), low IQ (aOR = 0.66, 95% CI: 0.41, 1.06), and HBP (aOR = 0.89, 95% CI: 0.77, 1.04). According to our data, term LGA infants with small catch-down growth had no increased risks of adverse outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 28992219     DOI: 10.1093/aje/kwx271

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Pathways Linking Birth Weight and Insulin Sensitivity in Early Adolescence: A Double Mediation Analysis.

Authors:  Andraea Van Hulst; Gilles Paradis; Andrea Benedetti; Tracie A Barnett; Mélanie Henderson
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

Review 2.  Childhood obesity and adverse cardiometabolic risk in large for gestational age infants and potential early preventive strategies: a narrative review.

Authors:  Sreekanth Viswanathan; Kera McNelis; Kartikeya Makker; Darlene Calhoun; Jessica G Woo; Babu Balagopal
Journal:  Pediatr Res       Date:  2021-12-16       Impact factor: 3.953

3.  Early-life determinants of excess weight in children born heavy.

Authors:  Amy R Goetz; Tiffany M Rybak; James L Peugh; Lori J Stark
Journal:  Pediatr Obes       Date:  2019-11-05       Impact factor: 3.910

4.  Neurodevelopmental outcomes of singleton large for gestational age infants <29 weeks' gestation: a retrospective cohort study.

Authors:  Deepika Rustogi; Anne Synnes; Belal Alshaikh; Shabih Hasan; Christine Drolet; Edith Masse; Prashanth Murthy; Prakesh S Shah; Kamran Yusuf
Journal:  J Perinatol       Date:  2021-05-25       Impact factor: 3.225

5.  Association of birthweight centiles and early childhood development of singleton infants born from 37 weeks of gestation in Scotland: A population-based cohort study.

Authors:  Abiodun Adanikin; Deborah A Lawlor; Jill P Pell; Scott M Nelson; Gordon C S Smith; Stamatina Iliodromiti
Journal:  PLoS Med       Date:  2022-10-11       Impact factor: 11.613

6.  Reduced glucose-stimulated insulin secretion following a 1-wk IGF-1 infusion in late gestation fetal sheep is due to an intrinsic islet defect.

Authors:  Alicia White; Jane Stremming; Brit H Boehmer; Eileen I Chang; Sonnet S Jonker; Stephanie R Wesolowski; Laura D Brown; Paul J Rozance
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-03       Impact factor: 5.900

7.  Associations between capillary glucose during pregnancy and childhood growth to the age of five: a cohort study.

Authors:  Anna Österroos; Linda Lindström; Per Wikman; Anna-Karin Wikström; Inger Sundström Poromaa; Fredrik Ahlsson
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.